...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

CfPIE Forms Partnership with BioOhio to Offer Life Sciences Training Benefits

| Print |
Tuesday, 01 October 2013 14:30 (UTC + 2)

CfPIE Logo

Educational advancement opportunities extended to Ohio bioscience members at a discounted rate

Malvern, PA, USA, October 1, 2013 / B3C newswire / - All courses and certification programs offered by The Center for Professional Innovation and Education (CfPIE), a quality resource for technical life sciences training, have been extended to BioOhio members at a 10% discount through a recent partnership to aid in the advancement of professional bioscience development.

“We are passionate about providing opportunities that enable acceleration of the bioscience industry, research, and education in Ohio.  Our partnership with CfPIE provides the benefits of a leading training resource at a value to our members”, says John F. Lewis, Jr., President and CEO of BioOhio. 

Among the comprehensive pharmaceutical, biotechnology, and medical device training curriculum, bioscience-specific courses include: 

cGMP Quality Principles for Pharmaceuticals, Biopharmaceuticals, Biologics and Medical Devices . This course will provide the participant knowledge of current Good Manufacturing Practices (GMPs), how they are applied in the pharmaceutical and biotechnology market today, and how they will be enforced in the future.

CMC Regulatory Compliance for Biopharmaceuticals and Biologics. This course will help the attendee to develop a CMC regulatory compliance strategy for biologics, while focusing on the core elements that comprise an effective plan.

Preparation of FDA Submission and Communicating with the FDA. This course will give participants the necessary overview of the US Food and Drug Administration's (FDA’s) current responsibilities, procedures, guidances and regulatory pathways that affect the review and approval of chemical drugs, biologicals, biopharmaceuticals, biosimilars and chemical generics.

Comprehensive Overview of FDA Regulatory Compliance. This course is designed to provide participants with an understanding of the parameters for regulatory compliance, successful approaches to compliance, and meeting the concerns of regulators.

BioOhio member discounted benefits include:

  • Robust selection of courses that satisfy scientific, administrative, regulatory compliance, and marketing needs, at every level of experience
  • Economical on-site training for multiple employees including company-specific content and a consistent experience for all employees
  • Flexible certification programs that enable individuals to tailor the qualifying courses of study, while enhancing professional credibility


About CfPIE 
The Center for Professional Innovation and Education (CfPIE) is the global leader in pharmaceutical, biotech, and medical device technical training within the life sciences industry.  CfPIE offers more than 350 class sessions annually across 71 course titles.  Multiple learning formats—classroom, customized on-site presentation and certification programs—provides individuals and companies versatile choices for improving personal skills, maintaining regulatory compliance, and creating opportunities for career advancement.  Small class sizes and life science industry-active course directors promote a dynamic learning environment with excellent student-to-teacher interaction.

 
Media Contact:

Jaclyn Solick
TME Communications for CfPIE
610- 688-0659 x 114
This e-mail address is being protected from spambots. You need JavaScript enabled to view it